Clinical Focus ›› 2016, Vol. 31 ›› Issue (1): 53-55.doi: 10.3969/j.issn.1004-583X.2016.01.013

Previous Articles     Next Articles

Expression and clinical significance of apolipoprotein M in inflammatory bowel disease

Wang Tingting, Wang Liangzhi   

  1. Department of Gastroenterology, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China
  • Received:2015-08-28 Online:2016-01-05 Published:2016-04-19
  • Contact: Wang Liangzhi, Email: wangdoc371@sohu.com

Abstract: Objective To investigate the expression and clinical value of serum apolipoprotein M (apoM) in patients with inflammatory bowel disease (IBD).Methods The levels of serum apoM and TNF-α in 101 IBD patients and 69 healthy individuals were measured by ELISA.Results The serum concentration of apoM was respectively (13.5±8.8) mg/L, (10.2±5.8) mg/L and (2.0±1.3) mg/L in ulcerative colitis (UC) patients, Crohn disease (CD) patients and healthy controls, and the level of serum apoM in UC patients was significantly higher than that of CD patients (P<0.05). Serum apoM concentrations in both UC and CD patients were significantly elevated with increased disease activity(P<0.05). In addition, serum apoM concentration and TNF-α concentration were positively correlated in IBD group (r=0.314,P=0.001), especially in CD subgroup (r=0.365,P=0.010).Conclusion The levels of serum apoM in UC and CD patients were correlated with disease activity and have potential application value in evaluating disease activity of IBD.

Key words: inflammatory bowel diseases, apolipoprotein M, disease activity

CLC Number: